Company Filing History:
Years Active: 2007
Title: Berthold Hocher: Innovator in Renal Dysfunction Treatment
Introduction
Berthold Hocher is a notable inventor based in Kleinmachnow, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of renal dysfunctions, diseases, and disorders.
Latest Patents
Hocher holds a patent for a method and pharmaceutical compositions aimed at treating or inhibiting renal dysfunctions, especially in diabetic patients. His invention focuses on the treatment and inhibition of renal dysfunction in larger mammals, particularly humans suffering from diabetes. The patent details the use of benzazepine-N-acetic acid derivatives, which contain an oxo-group in the α-position to the nitrogen atom and are substituted in position 3 by a 1-(carboxyalkyl)cyclopentylcarbonylamino radical. This innovation also encompasses salts, biolabile esters, and physiologically acceptable solvates suitable for treating patients with renal dysfunction, disease, or disorder.
Career Highlights
Hocher is associated with Solvay Pharmaceuticals GmbH, where he has been instrumental in advancing pharmaceutical research and development. His work has focused on creating effective treatments for patients with complex health issues, including those with syndrome X, hypertension, obesity, and metabolic disorders.
Collaborations
Throughout his career, Hocher has collaborated with esteemed colleagues such as Dirk Thormaehlen and Harald Waldeck. These partnerships have contributed to the development of innovative solutions in the pharmaceutical industry.
Conclusion
Berthold Hocher's contributions to the field of renal dysfunction treatment highlight his dedication to improving patient outcomes. His innovative patent reflects a significant advancement in pharmaceutical science, particularly for diabetic patients.